Chicago, Illinois
December 17, 2003
Fitch Ratings has
affirmed Monsanto Company's
(Monsanto) 'A-' senior unsecured debt rating, 'A-' bank loan
rating and 'F2' commercial paper rating. The ratings apply to
approximately $1.57 billion of outstanding debt. The Rating
Outlook has been revised to Negative from Stable.
The new
Rating Outlook reflects uncertainty regarding timing and the
amount of incremental liabilities that Monsanto may incur as a
result of Solutia Inc.'s (Solutia) filing for reorganization
under Chapter 11. Potential liabilities that may be assumed by
Monsanto resulting from bankruptcy court determinations are a
portion of Solutia's other post-retirement employee benefits
(OPEBs), under funded by approximately $475 million as disclosed
by Solutia at September 30, 2003 (with an average annual cash
cost of $60 million); environmental remediation costs, estimated
by Solutia at $30-$40 million annually; and litigation costs,
including the case against Solutia by the Pennsylvania
Department of Transportation. The ultimate level and the cash
consequences of the above mentioned liabilities and other
liabilities that may result from the Solutia reorganization are
uncertain.
Fitch is
also concerned about the timing and amount of share repurchases
in the intermediate term, in light of the potential impact of
incremental liabilities to free cash flow. Fitch anticipates the
company's adherence to a conservative financial policy, with
modest share repurchases. Monsanto continues to see declines in
the Roundup/glyphosate franchise revenues and profitability due
to increasing generic competition, but is managing market share
erosion through new product formulations, a high level of brand
name recognition and loyalty, an extensive bulk glyphosate
distribution network, and cost control initiatives. Fitch also
notes that the Seed and Genomics Segment profitability has
improved significantly. Leverage as measured by total
debt-to-EBITDA was 1.3 times (x) and interest coverage as
measured by EBITDA-to-interest incurred was approximately 14.8x
for the last 12 months at August 29, 2003.
Fitch
recognizes Monsanto's continued improvement in the balance
sheet, stronger liquidity and free cash flow generation, and
mitigation of litigation risk. The company has made strides in
controlling the seasonal effects on total debt, due to a
fluctuating receivables balance, through third-party funding
mechanisms for its customers, a larger cash balance, and a shift
of the capital structure to long-term obligations and away from
commercial paper borrowings. Monsanto's projection for year-end
2004 free cash flow (defined by net operating cash less net
investing cash) remains in the range of $350 million to $400
million, despite cash outflows associated with the resolution of
all property damage, personal injury and fear-of-future- injury
claims resulting from polychlorinated biphenyl (PCB)
contamination in Anniston, AL. The company had free cash flow of
approximately $640 million at the end of fiscal year 2003.
Monsanto
is a provider of herbicides, conventional and hybrid seeds, and
genetically modified seeds and traits to the agricultural
industry. The company holds leading positions in the glyphosate
herbicide market and in seeds and biotechnology traits. |